RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy
2023 · Nature · 245 citations
https://doi.org/10.1038/s41586-023-05771-9
M
Míriam Molina‐Arcas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
180
Papers
4.5K
Citations
33
h-index
45
i10-index
Míriam Molina‐Arcas is an academic researcher from The Francis Crick Institute. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Synthesis and Biological Evaluation & Synthesis and biological activity. The author has an h-index of 33, co-authored 153 publications.
ORCID: 0000-0002-8176-8948Papers by this author
worksDevelopment of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer
2019 · Science Translational Medicine · 220 citations
https://doi.org/10.1126/scitranslmed.aaw7999
SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers
2019 · Nature Communications · 80 citations
https://doi.org/10.1038/s41467-019-10367-x
IGF1-mediated human embryonic stem cell self-renewal recapitulates the embryonic niche
2020 · Nature Communications · 76 citations
https://doi.org/10.1038/s41467-020-14629-x
RAS signalling through PI3-Kinase controls cell migration via modulation of Reelin expression
2016 · Nature Communications · 63 citations
https://doi.org/10.1038/ncomms11245
Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs
2012 · BMC Cancer · 38 citations
https://doi.org/10.1186/1471-2407-12-434
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat